Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Director departure
Appointed director
CC transcript
Employment agrmnt
Preliminary results
Inv. presentation
BIOLASE, INC (BIOL) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/15/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
08/10/2023 8-K Quarterly results
Docs: "BIOLASE REPORTS RECORD CONSUMABLE SALES AS TOTAL SECOND QUARTER REVENUE INCREASES 17% YEAR OVER YEAR Continues to Experience Positive Momentum and Expects to Achieve Improved Net Income and Positive Adjusted EBITDA for the Second Half of 2023 LAKE FOREST, Calif., August 10, 2023"
07/26/2023 8-K Quarterly results
06/06/2023 8-K Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Yea...
Docs: "Certificate of Designation of the Series I Preferred Stock of the Company",
"BIOLASE ANNOUNCES DISTRIBUTION OF SERIES I PREFERRED STOCK TO HOLDERS OF ITS COMMON STOCK"
05/26/2023 8-K Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Amendments to Articles of I...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Underwriting Agreement, by and between BIOLASE, Inc. and Lake Street Capital Markets, LLC, as representative of the several underwriters named therein",
"Certificate of Designation of Preferences, Rights and Limitations of Series H Convertible Redeemable Preferred Stock",
"Warrant Agency Agreement, by and between BIOLASE, Inc., Computershare Inc., and its affiliate, Computershare Trust Company, N.A., a federal trust company",
"Form of Warrant to Purchase Shares of Series H Convertible Preferred Stock",
"BIOLASE Inc. Announces Pricing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants",
"BIOLASE Inc. Announces Closing of $4.5 Million Underwritten Public Offering of Series H Convertible Redeemable Preferred Stock and Warrants"
05/11/2023 8-K Quarterly results
Docs: "BIOLASE MAINTAINS MOMENTUM AND REPORTS NINTH CONSECUTIVE QUARTER OF YEAR-OVER-YEAR GROWTH; REITERATES FULL YEAR GUIDANCE OF AT LEAST 25% REVENUE GROWTH AND PROFITABILITY FOR FULL YEAR 2023 Educational and Training Programs Introducing Broader Community of Dentists to Experience Industry-Leading Dental Lasers for the First Time LAKE FOREST, Calif., May 11, 2023"
05/02/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
03/28/2023 8-K Quarterly results
01/18/2023 8-K Quarterly results
01/12/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
01/05/2023 8-K Credit agreement amendment
Docs: "Tenth Amendment to Credit Agreement, by and among BIOLASE, INC., each of the Lenders, and SWK FUNDING LLC, in its capacity as administrative agent for the other Lenders",
"Tenth Amendment to Credit Agreement, by and among BIOLASE, INC., each of the Lenders, and SWK FUNDING LLC, in its capacity as administrative agent for the other Lenders"
11/10/2022 8-K Quarterly results
09/28/2022 8-K Quarterly results
08/11/2022 8-K Quarterly results
07/07/2022 8-K Quarterly results
06/29/2022 8-K Quarterly results
06/08/2022 8-K Quarterly results
05/13/2022 8-K Quarterly results
05/12/2022 8-K Quarterly results
05/02/2022 8-K Quarterly results
03/17/2022 8-K Quarterly results
Docs: "BIOLASE REPORTS CONTINUED GROWTH FOR FOURTH QUARTER AND FULL YEAR 2021 • Robust Balance Sheet to Execute Growth Strategies in 2022 • Full Year 2022 Revenue Growth Outlook +10% Lake Forest, Calif., March 17, 2022"
03/03/2022 8-K Quarterly results
01/10/2022 8-K Preliminary quarterly results
Docs: "BIOLASE ANNOUNCES POSTIVE PRELIMINARY REVENUE RESULTS FOR 2021 FOURTH QUARTER; ENTERS 2022 WITH SIGNIFICANT MOMENTUM"
12/08/2021 8-K Quarterly results
11/23/2021 8-K Credit agreement amendment
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"NASDAQ GRANTS BIOLASE 180-DAY EXTENSION TO MEET MINIMUM BID PRICE REQUIREMENT AND ENTERS INTO FAVORABLE CREDIT AGREEMENT AMENDMENT"
11/18/2021 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
11/17/2021 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "BIOLASE Urges Stockholders to Vote Now “FOR” Reverse Stock Split"
11/10/2021 8-K Quarterly results
Docs: "BIOLASE REPORTS 46% REVENUE GROWTH IN 2021 THIRD QUARTER; DEMAND FOR DENTAL LASERS FROM NEW CUSTOMERS REMAINS HIGH AND CONTINUES TO FUEL GROWTH Expects Significant Revenue Growth Year-Over-Year in Fourth Quarter 2021 Foothill Ranch, Calif., November 10, 2021"
08/12/2021 8-K Quarterly results
Docs: "BIOLASE REPORTS SIGNIFICANTLY IMPROVED REVENUE IN ITS SECOND QUARTER AS CONTINUED HIGH DEMAND FOR DENTAL LASERS FROM NEW CUSTOMERS FUELED GROWTH Guides for Significant Revenue Growth Year-Over-Year in Third Quarter 2021 Foothill Ranch, Calif., August 12, 2021"
06/11/2021 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/26/2021 8-K Quarterly results
05/24/2021 8-K Quarterly results
05/13/2021 8-K Quarterly results
03/25/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy